MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

04 Nov 2023 Evaluate
The sales for the September 2023 quarter moved down to Rs. 396.54 millions as compared to Rs. 476.91 millions during the year-ago period.The Company to register a -32.93%  fall in the net profit for the quarter ended September 2023.The company reported a degrowth in operating Profit to 178.20 millions from 257.98 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 396.54 476.91 -16.85 892.42 926.35 -3.66 1489.73 1148.54 29.71
Other Income 10.01 13.96 -28.30 20.76 28.19 -26.36 60.24 40.50 48.74
PBIDT 178.20 257.98 -30.92 424.01 500.00 -15.20 802.42 620.96 29.22
Interest 0.51 0.42 21.43 0.76 1.04 -26.92 2.01 8.28 -75.72
PBDT 177.69 257.56 -31.01 423.25 498.96 -15.17 800.41 612.68 30.64
Depreciation 8.84 5.79 52.68 16.33 11.49 42.12 25.76 22.33 15.36
PBT 168.85 251.77 -32.93 406.92 487.47 -16.52 774.65 590.35 31.22
TAX 43.43 64.78 -32.96 104.29 122.77 -15.05 194.96 154.10 26.52
Deferred Tax 1.11 2.66 -58.27 2.07 0.74 179.73 2.55 0.72 254.17
PAT 125.42 186.99 -32.93 302.63 364.70 -17.02 579.69 436.25 32.88
Equity 72.64 72.64 0.00 72.64 72.64 0.00 72.64 72.64 0.00
PBIDTM(%) 44.94 54.09 -16.92 47.51 53.98 -11.97 53.86 54.07 -0.37
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..